BioBridges is pleased to announce the appointment of Larry Blandford, PharmD, to its Board of Directors. He will play a key role in shaping BioBridges’ strategic vision and expanding the...
By Manvi Sharma, PhD, Director of Real-World Evidence The life sciences industry is evolving rapidly, and the ability to harness real-world evidence (RWE) in life sciences is becoming a key...
The HEOR industry is constantly evolving – from new EU HTA regulations to the impact of AI. Our team recently attended ISPOR Europe in Barcelona, Spain, where John Cook, our Chief Scientific Officer, gave us his take on the compelling topics people were discussing this year.
BioBridges now offers complete Health Economics and Outcomes Research (HEOR) services. HEOR is a field of research that provides real-world data and insights to demonstrate the clinical and economic value of pharmaceutical products and medical devices.
In the dynamic landscape of Biotech, Pharma, and life sciences, Biopharma consultants play a pivotal role in driving success for Pharmaceutical companies, healthcare providers, and other key stakeholders. As a...
CHEORS Acquired by PharmAlliance PharmAlliance Announces the Acquisition of CHEORS Per the BusinessWire BioBridges is excited to be part of PharmAlliance, a growing pharmaceutical and life sciences services platform....
An emerging cellular therapeutics company was entering phase 1 clinical testing for their lead hematology candidate based on their antibody-coupled T-cell receptor (ACTR) technology. In order to move their vision for a singular therapeutic platform approach to treat many different cancers through the development process, they needed a plan, processes and hands-on support.